ELI Lilly has announced that its planned transition to the Mounjaro (tirzepatide) KwikPen is now complete, and the drug is only available in this presentation.
The previously available vial presentation is now discontinued, and Lilly said it is committed to ensuring the drug's ongoing availability.
The above article was sent to subscribers in Pharmacy Daily's issue from 30 Jun 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Jun 25
